Table: Peptidream -2020 parent results
Feb 10 (Reuters)-
Peptidream Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2020 Dec 31, 2019 Dec 31, 2021 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 11.68 1.04
Operating 6.99 loss 887 mln
Recurring 6.98 loss 706 mln
Net 4.45 loss 488 mln
EPS 35.40 yen loss 3.90 yen
EPS Diluted 34.26 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Peptidream Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4587.T
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner